These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31863395)

  • 1. Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study.
    Gliem M; Birtel J; Herrmann P; Fimmers R; Berger M; Coch C; Wingen A; Holz FG; Charbel Issa P
    Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):311-318. PubMed ID: 31863395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-VEGF treatment for choroidal neovascularization complicating pattern dystrophy-like deposit associated with pseudoxanthoma elasticum.
    Battaglia Parodi M; Romano F; Marchese A; Arrigo A; Llorenç V; Cicinelli MV; Bandello F; Adán A
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):273-278. PubMed ID: 30470876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a one-year prospective study.
    Finger RP; Charbel Issa P; Hendig D; Scholl HP; Holz FG
    Am J Ophthalmol; 2011 Oct; 152(4):695-703. PubMed ID: 21704964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal aflibercept for myopic choroidal neovascularization.
    Pece A; Milani P
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2327-2332. PubMed ID: 27286893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal aflibercept for management of subfoveal choroidal neovascularization secondary to angioid streaks.
    Esen E; Sizmaz S; Demircan N
    Indian J Ophthalmol; 2015 Jul; 63(7):616-8. PubMed ID: 26458482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum.
    Finger RP; Charbel Issa P; Schmitz-Valckenberg S; Holz FG; Scholl HN
    Retina; 2011; 31(7):1268-78. PubMed ID: 21386758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranibizumab for choroidal neovascularization secondary to pseudoxanthoma elasticum: 4-year results from the PIXEL study in France.
    Mimoun G; Ebran JM; Grenet T; Donati A; Cohen SY; Ponthieux A
    Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1651-1660. PubMed ID: 28493086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MULTIMODAL IMAGING OF FOCAL CHOROIDAL EXCAVATION COMPLICATED BY CHOROIDAL NEOVASCULARIZATION IN A PATIENT WITH ANGIOID STREAKS AND PSEUDOXANTHOMA ELASTICUM.
    Ferreira BFA; Preti RC; Schmidt MB; Zacharias LC; Takahashi WY; Monteiro MLR
    Retin Cases Brief Rep; 2021 Mar; 15(2):155-162. PubMed ID: 29965887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-VEGF Treatment for Secondary Neovascularization in Pseudoxanthoma Elasticum - Age of Onset, Treatment Frequency, and Visual Outcome.
    Raming K; Pfau M; Herrmann P; Holz FG; Pfau K
    Am J Ophthalmol; 2024 Sep; 265():127-136. PubMed ID: 38614195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum.
    Finger RP; Charbel Issa P; Ladewig M; Holz FG; Scholl HP
    Br J Ophthalmol; 2008 Apr; 92(4):483-7. PubMed ID: 18369065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum.
    Bhatnagar P; Freund KB; Spaide RF; Klancnik JM; Cooney MJ; Ho I; Fine HF; Yannuzzi LA
    Retina; 2007 Sep; 27(7):897-902. PubMed ID: 17891014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSEUDOXANTHOMA ELASTICUM: SUCCESSFUL LONG-TERM MANAGEMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO ANGIOID STREAKS WITH PRO RE NATA INTRAVITREAL BEVACIZUMAB INJECTIONS.
    Kim J; Dalziel D
    Retin Cases Brief Rep; 2021 May; 15(3):246-250. PubMed ID: 30048402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience of switching anti-VEGF therapy from ranibizumab to aflibercept in age-related choroidal neovascularization.
    Van Lancker L; Petrarca R; Moutsouris K; Masaoutis P; Kampougeris G
    Eur J Ophthalmol; 2017 May; 27(3):342-345. PubMed ID: 27739561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal aflibercept for submacular hemorrhage secondary to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Kim JH; Kim CG; Lee DW; Yoo SJ; Lew YJ; Cho HJ; Kim JY; Lee SH; Kim JW
    Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):107-116. PubMed ID: 31741044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal aflibercept for management of choroidal neovascularization secondary to angioid streaks : The Italian EYLEA-STRIE study.
    Parodi MB; Cicinelli MV; Marchese A; Giuffrè C; Viola F; Staurenghi G; Varano M; Bandello F
    Eur J Ophthalmol; 2021 May; 31(3):1146-1153. PubMed ID: 32483995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal aflibercept for the treatment of choroidal neovascularization associated with rubella retinopathy.
    Kiziltoprak H; Yetkin E; Tekin K; Koc M; Akalin İ; Teke MY
    Int Ophthalmol; 2019 Feb; 39(2):477-484. PubMed ID: 29411259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation.
    Chou HD; Wu WC; Wang NK; Chuang LH; Chen KJ; Lai CC
    BMC Ophthalmol; 2017 Jun; 17(1):104. PubMed ID: 28655307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INTRAVITREAL BEVACIZUMAB IN THE TREATMENT OF CHOROIDAL NEOVASCULAR MEMBRANE DUE TO ANGIOID STREAKS.
    Alagöz C; Alagöz N; Özkaya A; Çelik U; Turan MF; Yazici AT; Çekiç O; Demirok A
    Retina; 2015 Oct; 35(10):2001-10. PubMed ID: 25996427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-Year Outcomes of the Treat-and-Extend Approach with Aflibercept in Age-Related Macular Degeneration: Effects on Typical Choroidal Neovascularization and Retinal Angiomatous Proliferation.
    Castro-Navarro V; Cervera-Taulet E; Montero-Hernández J; Navarro-Palop C
    Ophthalmologica; 2016; 236(4):215-222. PubMed ID: 27997921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.